Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1985PDF: 1600HTML: 345 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2808PDF: 1310HTML: 3551Untitled: 171Untitled: 186Untitled: 162 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
690PDF: 57HTML: 126 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
390PDF: 206HTML: 71 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
964PDF: 1089Suppl. Files: 551HTML: 72 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1118PDF: 1006HTML: 175 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1297HTML: 368PDF: 793 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3634PDF: 1604HTML: 11482Figures Haase: 177 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1907PDF: 685HTML: 669Table1: patient's characteristics: 138Table 2: profile of each patient: 163 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3186PDF: 1910HTML: 7452 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2372HTML: 252PDF: 823 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8871PDF: 5957HTML: 87459Fig.1b: 164Fig.1c: 165Fig.2a: 156Fig.2b: 161Fig.4: 169Fig.2c: 158Fig.3: 163Tab.1: 212Tab.2: 191Tab.3: 177Tab.4: 198Fig1a: 158 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3439PDF: 1135HTML: 4975Incidence age-standardized rates for HL across the Mediterranean basin: 175 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3146PDF: 1683HTML: 1071 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2516PDF: 775HTML: 5175 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3428PDF: 2339HTML: 1411 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3501PDF: 834HTML: 6695 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1426PDF: 894HTML: 208 -
SOLITARY PLASMACYTOMA
3751PDF: 2127HTML: 1199fIGURES 1,2: 191 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2006PDF: 917HTML: 128Suppl. Files: 492 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3429PDF: 1579HTML: 2662 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2075PDF: 1524HTML: 248 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2973PDF: 836HTML: 7150Kost Fig1: 164Kost Fig 2: 156Kost Fig3: 151Kost Fig 4: 169Kost Fig5: 166Kost fig 6: 151 -
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2401PDF: 759HTML: 1721 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3829PDF: 1441HTML: 9171Untitled: 258Untitled: 163Untitled: 149Untitled: 145Untitled: 163Untitled: 316 -
-
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2695PDF: 1070HTML: 3253 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3958PDF: 1012HTML: 3556Untitled: 164Cneo. Fig.1: 99Untitled: 89Untitled: 112Untitled: 114 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 980HTML: 5497







